Skip to content
Screener

Solventum SOLV Operating Income

Operating Income at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$663M-24.8%
3M logo
3MMMM
$984M-13.7%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$2.65M+221%
Cardinal Health logo
Cardinal HealthCAH
$509M-30.3%
UnitedHealth Group logo
UnitedHealth GroupUNH
$8.99B-1.4%
DENTSPLY SIRONA logo
DENTSPLY SIRONAXRAY
$82M+164%

Segments

By segment

See full
MedSurg$355M+69.0%
Health Information Systems$145M+20.8%
Dental Solutions$131M+36.5%
Purification and Filtration Segment$0-100%

Other financials

Income statement

See full
Revenue$2.2B+2.2%
Gross profit$1.3B+9.4%
Net income$92.0M+2.2%
EPS (diluted)$0.53+3.9%

Balance sheet

See full
Cash & equivalents$403.0M-18.1%
Total debt$5.8B-25.9%
Total equity$4.8B+31.7%
Total assets$14.2B-5.5%

Cash flow

See full
Operating cash flow$227.0M+34.3%
CapEx$83.0M-24.5%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$15.23B+20.6%
Enterprise value$20.62B+3.3%
P/E10.6×-22.6×
P/S1.8×+0.3×

Profitability

See full
Gross margin54.7%+0.2pp
Operating margin25%+15.7pp
Net margin17.3%+12.7pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34%+22.3pp
Debt / equity1.2×-0.9×
Current ratio-0.2×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Solventum’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:27 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001964738-26-000047
(Millions, except per share data)Three months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Gross profit1,2861,1752,3822,289
Selling, general and administrative expenses9277721,7541,541
Research and development expenses178189367381
Operating income181214262367
Interest expense, net64103125207
Other expense (income), net981319
Income before income taxes108103123141
Provision for (benefit from) income taxes151319(86)

Item 1. Financial Statements

FAQ

What is Solventum's operating income?
Solventum (SOLV) reported operating income of $181M in Q2 2026.
How has Solventum's operating income changed year-over-year?
Solventum's operating income decreased by 15.4% year-over-year, from $214M to $181M.
What is the long-term trend for Solventum's operating income?
Over 3 years (2022 to 2025), Solventum's operating income has grown at a 8.8% compound annual growth rate (CAGR), from $1.69B to $2.18B.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Solventum's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude